의료기기용 전극 시장 규모, 점유율, 동향 분석 : 유형별, 지역별, 부문 예측(2025-2030년)

Electrodes For Medical Devices Market Size, Share & Trends Analysis Report By Type (Diagnostics (Electrocardiogram, Electroencephalogram, Electromyogram), Therapeutics), By Region (North America, Europe, APAC), And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,401,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,813,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,637,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

의료기기용 전극 시장의 성장과 동향 :

Grand View Research의 최신 보고서에 따르면 세계 의료기기용 전극 시장 규모는 2030년까지 27억 달러에 달할 것으로 예측됩니다.

이 시장은 2025년부터 2030년에 걸쳐 CAGR 6.5%를 나타낼 것으로 예상됩니다. 이 시장은 심장병, 파킨슨병(PD), 알츠하이머병, 뇌질환, 삼차신경통(TN 또는 TGN), 부비강염, 이명, 레이노병, 섬유근통증, 순환장애, 통풍, 신체통증 등의 만성 질환 및 기타 질환의 유병률이 세계적으로 증가하고 있기 때문에 예측 기간 중에 수익성 있는 성장을 할 것으로 추정됩니다.

최소 침습 수술(MIS)은 복강경, 내시경, 관절경 및 기타 수술을 위해 신체에 작은 절개를 추가하는 의료 기술의 진보 중 하나입니다. 이 수술은 회복이 빠르고, 수술 후 감염과 통증, 대출혈이 적고, 흉터가 적고, 정밀도가 높다는 장점으로 인기를 끌고 있습니다. 2015년에는 2천만 명이 넘는 미국인들이 MIS를 받고 있으며 예측 기간 동안 이 분야의 성장을 지원할 것으로 기대되고 있습니다.

의료기기용 전극 시장 : 분석 개요

• 진단 분야가 2024년 시장을 독점했습니다. 최근 몇 년동안 심혈관 질환, 신경 질환 및 수면장애가 증가하고 있으며 세계에서 실시되는 진단 절차의 수가 증가하고 있습니다.
• 심장질환, 태아성 고통증후군, 안질환, 신경질환의 유병률 상승으로 심전도(ECG), 뇌파(EEG), 전기수술, 태아두피전극이 널리 사용되고 있습니다.
• 치료 분야에서는 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예측됩니다. 치료 분야는 심장 박동기, 경피적 전기 신경 자극 장치(TENS), 제세동기, 전기 수술 등으로 분류됩니다.
• 제세동기와 전기 수술용 전극은 예측 기간 동안 상당한 시장 점유율을 차지할 것으로 예측됩니다. 이는 착용자의 심장 리듬을 지속적으로 모니터링하고 이상 발생을 확인하고 사용자에게 알리고 정상적인 심장 기능을 회복시키는 웨어러블 제세동기의 개발이 진행되고 있기 때문입니다.
• 북미는 이 지역의 CVD 유병률 증가, 개인 라이프스타일 변화, 사람들의 건강 의식, 미국과 캐나다에서 표적층의 존재로 인해 2024년에 42.8%의 최대 수익 점유율을 차지했습니다.
• 아시아태평양은 예측 기간 동안 12.7%의 연평균 복합 성장률(CAGR)로 가장 빠른 성장이 예상됩니다. 이는 이 지역에서 만성 질환의 존재, 건강 의식에 관한 정부의 이니셔티브, 의료 분야에 대한 투자의 급증에 기인합니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 의료기기용 전극 시장 : 변동 요인·경향·범위

• 시장 연관 전망
  • 상위 시장 전망
  • 관련/부수시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 의료기기용 전극 시장 : 분석 툴
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석

제4장 의료기기용 전극 시장 : 유형별 추정과 동향 분석

• 세계의 의료기기용 전극 시장 : 유형별 대시보드
• 세계의 의료기기용 전극 시장 : 유형별 변동 분석
• 세계의 의료기기용 전극 시장 : 유형별(수익 베이스)
• 진단용
  • 심전도(ECG)
  • 뇌파(EEG)
  • 근전도(EMG)
  • 망막전도(ERG)
  • 태아의 두피
  • 기타
• 치료용
  • 페이스메이커
  • 경피 전기 신경 자극 장치
  • 제세동기
  • 전기 수술
  • 기타

제5장 의료기기용 전극 시장 :지역별 추정·동향 분석

• 지역별 대시보드
• 시장 규모 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제6장 경쟁 구도

• 기업/경쟁의 분류
• 벤더 상황
  • 주요 기업의 시장 점유율 분석(2024년)
  • 3M
  • Boston Scientific Corporation
  • GE Healthcare
  • CONMED Corporation
  • Medtronic
  • Natus Medical Incorporated
  • Thermo Fisher Scientific Inc.
  • Koninklijke Philips NV
  • X-trodes

KTH

영문 목차

영문목차

Electrodes For Medical Devices Market Growth & Trends:

The global electrodes for medical devices market size is anticipated to reach USD 2.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 6.5% from 2025 to 2030. The market is anticipated to witness lucrative growth during the forecast period, owing to increasing prevalence of chronic and other diseases such as heart diseases, Parkinson's Disease (PD), Alzheimer's disease, brain disorders, Trigeminal Neuralgia (TN or TGN), sinusitis, tinnitus, Raynaud's disease, fibromyalgia, circulatory disturbances, gout, and body ache, across the globe.

Minimally Invasive Surgery (MIS) is one of the advancements in medical technology in which small incisions are made in the body for laparoscopy, endoscopy, arthroscopy, and other surgical procedures. This procedure is gaining popularity owing to faster recovery, lesser postsurgical infections, pain, & major bleeding, reduced scarring, and high accuracy benefits. In 2015, over 20.0 million Americans underwent MIS, which is expected to assist in the growth of this vertical during the forecast period.

Electrodes For Medical Devices Market Report Highlights:

• The diagnostics segment dominated the market in 2024. There has been an increase in the number of cardiovascular, neurological, and sleep disorders in the last few years, which has led to an increase in the number of diagnostics procedures being carried out around the world.
• Rising prevalence of heart diseases, fetal distress syndrome, ocular diseases, and neurological disorders make extensive use of Electrocardiogram (ECG), Electroencephalogram (EEG), electrosurgical, and fetal scalp electrodes
• The therapeutics segment is expected to grow at the fastest CAGR during the forecasted period. The therapeutics segment is further classified into pacemakers, Transcutaneous Electrical Nerve Stimulators (TENS), defibrillators, electrosurgical, and others.
• Defibrillator and electrosurgical electrodes are projected to hold substantial market share over the forecast period. This can be attributed to the advanced development of wearable defibrillator that constantly monitors the cardiac rhythms of the wearer and identifies & notifies the user about the occurrence of any abnormality and helps regain the normal heart functionality
• North America held the largest revenue share of 42.8% in 2024 due to the increasing prevalence of CVD in the region, the changing lifestyle of individuals, health awareness among people, and the presence of the target audience in the U.S. and Canada.
• Asia Pacific is expected to grow at the fastest CAGR of 12.7% over the forecast period. This can be attributed to the presence of chronic diseases in the region, government initiatives regarding health awareness & surge in investment in the healthcare sector.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type scope
  • 1.2.2. Regional scope
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Electrodes For Medical Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing demand for minimally invasive procedures.
    • 3.2.1.2. Rising prevalence of chronic cardiovascular diseases
    • 3.2.1.3. Technological advancements in electrode materials and designs
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced electrodes and devices
    • 3.2.2.2. Stringent regulatory approval processes, delaying product launches
• 3.3. Electrodes For Medical Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Electrodes For Medical Devices Market: Type Estimates & Trend Analysis

• 4.1. Global Electrodes For Medical Devices Market: Type Dashboard
• 4.2. Global Electrodes For Medical Devices Market: Type Movement Analysis
• 4.3. Global Electrodes For Medical Devices Market by Type, Revenue
• 4.4. Diagnostics
  • 4.4.1. Diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Electrocardiogram (ECG)
    • 4.4.2.1. Electrocardiogram (ECG) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Electroencephalogram (EEG)
    • 4.4.3.1. Electroencephalogram (EEG) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Electromyogram (EMG)
    • 4.4.4.1. Electromyogram (EMG) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Electroretinogram (ERG)
    • 4.4.5.1. Electroretinogram (ERG) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.6. Fetal Scalp
    • 4.4.6.1. Fetal scalp market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.7. Others
    • 4.4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Therapeutics
  • 4.5.1. Therapeutics market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Pacemaker
    • 4.5.2.1. Pacemaker market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Transcutaneous electrical nerve stimulator
    • 4.5.3.1. Transcutaneous electrical nerve stimulator market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.4. Defibrillator
    • 4.5.4.1. Defibrillator market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.5. Electrosurgical
    • 4.5.5.1. Electrosurgical market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5.6. Others
    • 4.5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Electrodes For Medical Devices Market: Regional Estimates & Trend Analysis by Type

• 5.1. Regional Dashboard
• 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 5.3. North America
  • 5.3.1. U.S.
    • 5.3.1.1. Key country dynamics
    • 5.3.1.2. Regulatory framework/ reimbursement structure
    • 5.3.1.3. Competitive scenario
    • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.2. Canada
    • 5.3.2.1. Key country dynamics
    • 5.3.2.2. Regulatory framework/ reimbursement structure
    • 5.3.2.3. Competitive scenario
    • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.3. Mexico
    • 5.3.3.1. Key country dynamics
    • 5.3.3.2. Regulatory framework/ reimbursement structure
    • 5.3.3.3. Competitive scenario
    • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 5.4. Europe
  • 5.4.1. UK
    • 5.4.1.1. Key country dynamics
    • 5.4.1.2. Regulatory framework/ reimbursement structure
    • 5.4.1.3. Competitive scenario
    • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Germany
    • 5.4.2.1. Key country dynamics
    • 5.4.2.2. Regulatory framework/ reimbursement structure
    • 5.4.2.3. Competitive scenario
    • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. France
    • 5.4.3.1. Key country dynamics
    • 5.4.3.2. Regulatory framework/ reimbursement structure
    • 5.4.3.3. Competitive scenario
    • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Italy
    • 5.4.4.1. Key country dynamics
    • 5.4.4.2. Regulatory framework/ reimbursement structure
    • 5.4.4.3. Competitive scenario
    • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Spain
    • 5.4.5.1. Key country dynamics
    • 5.4.5.2. Regulatory framework/ reimbursement structure
    • 5.4.5.3. Competitive scenario
    • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Norway
    • 5.4.6.1. Key country dynamics
    • 5.4.6.2. Regulatory framework/ reimbursement structure
    • 5.4.6.3. Competitive scenario
    • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.7. Sweden
    • 5.4.7.1. Key country dynamics
    • 5.4.7.2. Regulatory framework/ reimbursement structure
    • 5.4.7.3. Competitive scenario
    • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.8. Denmark
    • 5.4.8.1. Key country dynamics
    • 5.4.8.2. Regulatory framework/ reimbursement structure
    • 5.4.8.3. Competitive scenario
    • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Asia Pacific
  • 5.5.1. Japan
    • 5.5.1.1. Key country dynamics
    • 5.5.1.2. Regulatory framework/ reimbursement structure
    • 5.5.1.3. Competitive scenario
    • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.2. China
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Regulatory framework/ reimbursement structure
    • 5.5.2.3. Competitive scenario
    • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.3. India
    • 5.5.3.1. Key country dynamics
    • 5.5.3.2. Regulatory framework/ reimbursement structure
    • 5.5.3.3. Competitive scenario
    • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.4. Australia
    • 5.5.4.1. Key country dynamics
    • 5.5.4.2. Regulatory framework/ reimbursement structure
    • 5.5.4.3. Competitive scenario
    • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.5. South Korea
    • 5.5.5.1. Key country dynamics
    • 5.5.5.2. Regulatory framework/ reimbursement structure
    • 5.5.5.3. Competitive scenario
    • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.6. Thailand
    • 5.5.6.1. Key country dynamics
    • 5.5.6.2. Regulatory framework/ reimbursement structure
    • 5.5.6.3. Competitive scenario
    • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Latin America
  • 5.6.1. Brazil
    • 5.6.1.1. Key country dynamics
    • 5.6.1.2. Regulatory framework/ reimbursement structure
    • 5.6.1.3. Competitive scenario
    • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6.2. Argentina
    • 5.6.2.1. Key country dynamics
    • 5.6.2.2. Regulatory framework/ reimbursement structure
    • 5.6.2.3. Competitive scenario
    • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. MEA
  • 5.7.1. South Africa
    • 5.7.1.1. Key country dynamics
    • 5.7.1.2. Regulatory framework/ reimbursement structure
    • 5.7.1.3. Competitive scenario
    • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.2. Saudi Arabia
    • 5.7.2.1. Key country dynamics
    • 5.7.2.2. Regulatory framework/ reimbursement structure
    • 5.7.2.3. Competitive scenario
    • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.3. UAE
    • 5.7.3.1. Key country dynamics
    • 5.7.3.2. Regulatory framework/ reimbursement structure
    • 5.7.3.3. Competitive scenario
    • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7.4. Kuwait
    • 5.7.4.1. Key country dynamics
    • 5.7.4.2. Regulatory framework/ reimbursement structure
    • 5.7.4.3. Competitive scenario
    • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company/Competition Categorization
• 6.2. Vendor Landscape
  • 6.2.1. Key company market share analysis, 2024
  • 6.2.2. 3M
    • 6.2.2.1. Company overview
    • 6.2.2.2. Financial performance
    • 6.2.2.3. Product benchmarking
    • 6.2.2.4. Strategic initiatives
  • 6.2.3. Boston Scientific Corporation
    • 6.2.3.1. Company overview
    • 6.2.3.2. Financial performance
    • 6.2.3.3. Product benchmarking
    • 6.2.3.4. Strategic initiatives
  • 6.2.4. GE Healthcare
    • 6.2.4.1. Company overview
    • 6.2.4.2. Financial performance
    • 6.2.4.3. Product benchmarking
    • 6.2.4.4. Strategic initiatives
  • 6.2.5. CONMED Corporation
    • 6.2.5.1. Company overview
    • 6.2.5.2. Financial performance
    • 6.2.5.3. Product benchmarking
    • 6.2.5.4. Strategic initiatives
  • 6.2.6. Medtronic
    • 6.2.6.1. Company overview
    • 6.2.6.2. Financial performance
    • 6.2.6.3. Product benchmarking
    • 6.2.6.4. Strategic initiatives
  • 6.2.7. Natus Medical Incorporated
    • 6.2.7.1. Company overview
    • 6.2.7.2. Financial performance
    • 6.2.7.3. Product benchmarking
    • 6.2.7.4. Strategic initiatives
  • 6.2.8. Thermo Fisher Scientific Inc.
    • 6.2.8.1. Company overview
    • 6.2.8.2. Financial performance
    • 6.2.8.3. Product benchmarking
    • 6.2.8.4. Strategic initiatives
  • 6.2.9. Koninklijke Philips N.V.
    • 6.2.9.1. Company overview
    • 6.2.9.2. Financial performance
    • 6.2.9.3. Product benchmarking
    • 6.2.9.4. Strategic initiatives
  • 6.2.10. X-trodes
    • 6.2.10.1. Company overview
    • 6.2.10.2. Financial performance
    • 6.2.10.3. Product benchmarking
    • 6.2.10.4. Strategic initiatives

관련자료